BioCentury | Apr 15, 2013
Clinical News

P280-technetium-99m targeting platelet receptor GPIIb/IIIa data

...DVT. Previous estimates are that 33 percent of patients with recurrent symptoms have acute thrombus. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

P483H-technetium-99m peptide heparin complex data

...sites. One false negative and one false positive result was generated by the imaging agent. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

Tin-117m DTPA data

...isotopes (samarium, strontium, and rhenium). Pain relief was comparable to that with the other agents. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

P829 radiolabeled peptide binding somatostatin receptors data

...Data were presented at the meeting of the Radiological Society of North America in Chicago. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

P829 radiolabeled peptide binding somatostatin receptors data

...Data were presented at the meeting of the Radiological Society of North America in Chicago. Diatide Inc....
BioCentury | Dec 15, 2003
Finance

Ebb & Flow

...public and subsequently sold it to pharma. The new CEO, Richard Dean, founded imaging company Diatide...
...1996 at a post-money valuation of $87 million. Three years later, Schering (FSE:SCH; SHR) bought Diatide...
BioCentury | Oct 14, 2002
Strategy

Spendthrifty

...consultant, Hawthorne was brought in to help get lifeboat financing and find a buyer for Diatide Inc....
BioCentury | May 21, 2001
Company News

Gemini Genomics management update

...Center; and Patricia McDaniels as head of intellectual property management, formerly a patent attorney with Diatide Inc. WIR...
BioCentury | Jan 4, 2000
Finance

1999 M&A activity

...Bioscience $492.0 Baxter North American Vaccine $390.0 Becton Dickinson Clontech $200.0 Biovail Fuisz $154.0 Schering Diatide...
BioCentury | Nov 8, 1999
Company News

Diatide, Schering deal

...DITI for $9.50 per share in cash, or about $130 million (see BioCentury, Sept. 27). Diatide Inc....
Items per page:
1 - 10 of 82
BioCentury | Apr 15, 2013
Clinical News

P280-technetium-99m targeting platelet receptor GPIIb/IIIa data

...DVT. Previous estimates are that 33 percent of patients with recurrent symptoms have acute thrombus. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

P483H-technetium-99m peptide heparin complex data

...sites. One false negative and one false positive result was generated by the imaging agent. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

Tin-117m DTPA data

...isotopes (samarium, strontium, and rhenium). Pain relief was comparable to that with the other agents. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

P829 radiolabeled peptide binding somatostatin receptors data

...Data were presented at the meeting of the Radiological Society of North America in Chicago. Diatide Inc....
BioCentury | Apr 15, 2013
Clinical News

P829 radiolabeled peptide binding somatostatin receptors data

...Data were presented at the meeting of the Radiological Society of North America in Chicago. Diatide Inc....
BioCentury | Dec 15, 2003
Finance

Ebb & Flow

...public and subsequently sold it to pharma. The new CEO, Richard Dean, founded imaging company Diatide...
...1996 at a post-money valuation of $87 million. Three years later, Schering (FSE:SCH; SHR) bought Diatide...
BioCentury | Oct 14, 2002
Strategy

Spendthrifty

...consultant, Hawthorne was brought in to help get lifeboat financing and find a buyer for Diatide Inc....
BioCentury | May 21, 2001
Company News

Gemini Genomics management update

...Center; and Patricia McDaniels as head of intellectual property management, formerly a patent attorney with Diatide Inc. WIR...
BioCentury | Jan 4, 2000
Finance

1999 M&A activity

...Bioscience $492.0 Baxter North American Vaccine $390.0 Becton Dickinson Clontech $200.0 Biovail Fuisz $154.0 Schering Diatide...
BioCentury | Nov 8, 1999
Company News

Diatide, Schering deal

...DITI for $9.50 per share in cash, or about $130 million (see BioCentury, Sept. 27). Diatide Inc....
Items per page:
1 - 10 of 82